In a regulatory filing, Chemed president and CEO Kevin McNamara disclosed the sale of 1,500 common shares of the company on June 6 at a price of $544.17 per share.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHE: